Safety and tolerability of lanreotide autogel/depot (LAN) in patients (pts) with neuroendocrine tumors (NETs): Pooled analysis of clinical studies. Meeting Abstract

publication date

  • February 1, 2017

webpage

published in

volume

  • 35

issue

  • 4